|
Omburo, G A; Jacobitz, S; Torphy, T J et al. (1998) Critical role of conserved histidine pairs HNXXH and HDXXH in recombinant human phosphodiesterase 4A. Cell Signal 10:491-7
|
|
Omburo, G A; Torphy, T J; Scott, G et al. (1997) Inactivation of recombinant monocyte cAMP-specific phosphodiesterase by cAMP analog, 8-[(4-bromo-2,3-dioxobutyl)thio]adenosine 3',5'-cyclic monophosphate. Blood 89:1019-26
|
|
Sheth, S B; Brennan, K J; Biradavolu, R et al. (1997) Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells. Thromb Haemost 77:155-62
|
|
Sheth, S B; Chaganti, K; Bastepe, M et al. (1997) Cyclic AMP phosphodiesterases in human lymphocytes. Br J Haematol 99:784-9
|
|
Cheung, P P; Xu, H; McLaughlin, M M et al. (1996) Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis. Blood 88:1321-9
|
|
Ghazaleh, F A; Omburo, G A; Colman, R W (1996) Evidence for the presence of essential histidine and cysteine residues in platelet cGMP-inhibited phosphodiesterase. Biochem J 317 ( Pt 2):495-501
|
|
Sheth, S B; Colman, R W (1995) Regulatory and catalytic domains of platelet cAMP phosphodiesterases: targets for drug design. Semin Hematol 32:110-9
|
|
Omburo, G A; Brickus, T; Ghazaleh, F A et al. (1995) Divalent metal cation requirement and possible classification of cGMP-inhibited phosphodiesterase as a metallohydrolase. Arch Biochem Biophys 323:1-5
|
